Research Article
Biomarker Modulation Study of Celecoxib for Chemoprevention in Women at Increased Risk for Breast Cancer: A Phase II Pilot Study
Soley Bayraktar, Sema Baghaki, Jimin Wu, Diane D. Liu, Angelica M. Gutierrez-Barrera, Therese B. Bevers, Vicente Valero, Nour Sneige and Banu K. Arun
Soley Bayraktar
1Division of Medical Oncology and Hematology, Department of Medicine, Biruni University School of Medicine, Istanbul, Turkey.
2Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Sema Baghaki
2Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Jimin Wu
3Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Diane D. Liu
3Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Angelica M. Gutierrez-Barrera
2Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Therese B. Bevers
4Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Vicente Valero
2Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Nour Sneige
5Department of Cytopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Banu K. Arun
2Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
DOI: 10.1158/1940-6207.CAPR-20-0095 Published September 2020

Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
September 2020
Volume 13, Issue 9
Volume 13, Issue 9
Biomarker Modulation Study of Celecoxib for Chemoprevention in Women at Increased Risk for Breast Cancer: A Phase II Pilot Study
Soley Bayraktar, Sema Baghaki, Jimin Wu, Diane D. Liu, Angelica M. Gutierrez-Barrera, Therese B. Bevers, Vicente Valero, Nour Sneige and Banu K. Arun
Cancer Prev Res September 1 2020 (13) (9) 795-802; DOI: 10.1158/1940-6207.CAPR-20-0095
Biomarker Modulation Study of Celecoxib for Chemoprevention in Women at Increased Risk for Breast Cancer: A Phase II Pilot Study
Soley Bayraktar, Sema Baghaki, Jimin Wu, Diane D. Liu, Angelica M. Gutierrez-Barrera, Therese B. Bevers, Vicente Valero, Nour Sneige and Banu K. Arun
Cancer Prev Res September 1 2020 (13) (9) 795-802; DOI: 10.1158/1940-6207.CAPR-20-0095
Jump to section
Advertisement